Drug profile · INN
vamorolone
AGAMREE
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
vamorolone (AGAMREE) is an FDA-listed pharmaceutical active ingredient. Associated with CATALYST PHARMACEUTICALS, INC.. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN vamorolone
Brand AGAMREE
Route ORAL
Formulation SUSPENSION
ATC code H02AB18
Originator CATALYST PHARMACEUTICALS, INC.
Frequently asked questions
What is vamorolone?
vamorolone (AGAMREE) is an FDA-listed pharmaceutical active ingredient. Associated with CATALYST PHARMACEUTICALS, INC.. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for vamorolone?
AGAMREE is a marketed brand name for vamorolone. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of vamorolone?
vamorolone has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.